Log In
Print this Print this

1095 (formerly MIP-1095)

  Manage Alerts
Collapse Summary General Information
Company Progenics Pharmaceuticals Inc.
DescriptionProstate-specific membrane antigen (PSMA) targeted iodine-131 labeled small molecule radiopharmaceutical
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat metastatic prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today